Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Terminated 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 18Lymphoid 4Other hematologic neoplasm 3Thoracic 2Plasma cell 2Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 266Osteosarcoma 81Sarcoma, Ewing 51Melanoma 44Neoplasms 43Gastrointestinal Stromal Tumors 41Colorectal Neoplasms 39Breast Neoplasms 38Rhabdomyosarcoma 36Bone Neoplasms 36Ovarian Neoplasms 32Neoplasm Metastasis 32Neuroblastoma 30Pancreatic Neoplasms 29Stomach Neoplasms 27Dendritic Cell Sarcoma, Interdigitating 27Lung Neoplasms 26Liposarcoma 26Leiomyosarcoma 26Glioblastoma 23Uterine Cervical Neoplasms 22Sarcoma, Synovial 22Head and Neck Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Esophageal Neoplasms 21Lymphoma 19Sarcoma, Kaposi 18Prostatic Neoplasms 18Carcinoma, Hepatocellular 18Urinary Bladder Neoplasms 17

Interventions

pegfilgrastim 1Vincristine 1Rituximab 1Prednisolone 1Lenalidomide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cardiotoxicity × Sarcoma × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡